Public market insider selling at Advanz Pharma (ADVZ)

Public market insider selling at Advanz Pharma (T:ADVZ)

Solus Alternative Asset Management LP, a 10% Holder, disposed of 42,400 Limited Voting Shares on a control or direction basis for registered holder Certain funds and accounts managed by Solus Alternative Asset Management LP and/or subsidiaries thereof at prices ranging from $26.010 to $26.415 between December 18th, 2018 and December 21st, 2018. This represents a $1,115,190 divestment of the company's shares and an account share holdings change of -0.5%.

Advanz Pharma is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Advanz Pharma Corp, formerly Concordia International Corp, is a Canada-based pharmaceutical company. It is an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, and sales in more than 90 countries. The Company is focused on investing in its product portfolio, bringing further opportunity for healthcare providers to optimise treatment. The Company does this through product acquisitions, in-licensing opportunities, product development and alliances worldwide.The Company, through subsidiaries, owns a portfolio of branded and generic prescription products and operates out of facilities in Bridgetown, Barbados, London, England and Mumbai, India Mississauga and Ontario.